Medical Communications

Showing 15 posts of 6402 posts found.

top_10_image_2_1

Top Ten most popular articles on Pharmafile.com this week

November 20, 2020 Medical Communications

The top ten news stories this week centre around coronavirus vaccine clinical trial results, as Pfizer and BioNTech have backed …

OPEN Health reveals new CEO appointment

November 19, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Open Health

Rob Barker has been named as the new Chief Executive Officer (CEO) at health communications and market access group OPEN …
shutterstock_2

Israel to reserve 8m doses of Pfizer/BioNTech’s COVID-19 vaccine

November 13, 2020 Manufacturing and Production, Medical Communications BioNTech, COVID-19, Pfizer, Vaccine, israel

Israeli Health Minister Yuli Edelstein has confirmed the nation’s plans to strike an agreement with Pfizer to secure eight million …
guido_rasi

Guido Rasi steps down as EMA’s Executive Director, Emer Cooke to become first female in the role

November 13, 2020 Medical Communications, Research and Development, Sales and Marketing COVID-19, EMA, EU, pharma

Professor Guido Rasi, Executive Director at the European Medicines Agency (EMA), serves his final day at the European regulator today, …
flu_vaccination_grippe_5115654021_1

India preparing 100 million doses of AstraZeneca’s COVID-19 vaccine for inoculation programme

November 13, 2020 Medical Communications

India is aiming to have 100 million doses of AstraZeneca’s COVID-19 vaccine ready for an inoculation drive beginning next month. …
1199px-india_-_varanasi_pharmacy_-_0830

World Health Organization to set up traditional medicines centre in India

November 13, 2020 Medical Communications

The World Health Organization announced today that it will set up the Global Centre for Traditional Medicine in India.  General …
top_10_image_2

Top Ten most popular articles on Pharmafile.com this week

November 13, 2020 Medical Communications

The top ten news stories this week focus on COVID-19 vaccines, with clinical trial participants who received the Pfizer/BioNTech coronavirus …

China approves Astellas’ Xtandi in non-metastatic castration-resistant prostate cancer

November 6, 2020 Medical Communications, Sales and Marketing Astellas, China, NMPA, Xtandi

China’s drug regulator, the National Medical Products Administration (NMPA), has given the green light to Astellas to market Xtandi (enzalutamide …
jnjioffice

Johnson & Johnson and three drug distributors close to $26 billion settlement

November 6, 2020 Medical Communications

Johnson & Johnson, McKesson, Cardinal Health and AmerisourceBergen are close to a $26 billion deal with local and state governments …
china_red_flag

US Department of Justice looking into Pfizer’s operations in China

November 6, 2020 Medical Communications

The US Department of Justice and the US Securities and Exchange Commission (SEC) are investigating Pfizer’s operations in China after …
novartis_outside_1

Novartis’ arthritis therapy shows no efficacy in hospitalised COVID-19 patients

November 6, 2020 Medical Communications, Research and Development COVID-19, Novatis, canakinumab

Novartis has revealed that its arthritis drug, theinterleukin-1 beta inhibitor canakinumab, in combination with standard of care (SoC), failed to …
top_10_image_2

Pharmafile.com’s weekly COVID-19 news round-up

November 6, 2020 Medical Communications COVID, COVID-19, EC, FDA, coronavirus

The top ten news stories this week focus on regulatory approvals as the European Commission has approved GlaxoSmithKline’s Zeljula as …
tt

How the US election could affect the pharmaceutical industry

November 4, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Donald Trump, Joe Biden, Trump, US, US election 2020, pharma

The US is one of the most lucrative markets for the pharmaceutical industry. This is a country where a lack of …
covid_cell_1

Pharmafile.com’s weekly COVID-19 news round-up

November 4, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, GSK, Sanofi, UK, US, remdesivir

As European nations fall one by one back into lockdown, hopes weigh heavily on a vaccine to pave a path …
nice_new_london_office_internal_3_web

NICE recommends Novo’s liraglutide for management of obesity and non-diabetic hyperglycaemia

October 30, 2020 Medical Communications, Sales and Marketing NICE, Novo Nordisk, liraglutide

Novo Nordisk’s pre-filled injection Saxenda (liraglutide) has received the backing of drug watchdog NICE, meaning it will now be made …
The Gateway to Local Adoption Series

Latest content